A paradigm shift in the monitoring of patients with acromegaly: Last available growth hormone may overestimate risk

  1. Sherlock, M.
  2. Reulen, R.C.
  3. Aragon-Alonso, A.
  4. Ayuk, J.
  5. Clayton, R.N.
  6. Sheppard, M.C.
  7. Hawkins, M.M.
  8. Bates, A.S.
  9. Stewart, P.M.
Revue:
Journal of Clinical Endocrinology and Metabolism

ISSN: 0021-972X 1945-7197

Année de publication: 2014

Volumen: 99

Número: 2

Pages: 478-485

Type: Article

DOI: 10.1210/JC.2013-2450 GOOGLE SCHOLAR lock_openAccès ouvert editor